P
Purple Biotech Ltd D
D
PPBT
2.79000
USD
0.63
(29.17%)
Market Closed
Volume
390
EPS
-1
Div Yield
-
P/E
0
Market Cap
4,369,397
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Purple Biotech Ltd
Sector: Healthcare
Industry: Biotechnology
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.